EuclidSR Partners, L.P.

10% owner at GYRE THERAPEUTICS, INC. · on record since Apr 18, 2006
10% owner at SPECTRASCIENCE INC · on record since Nov 16, 2007
10% owner at STANDARD BIOTOOLS INC. · on record since Feb 17, 2011
Director at AVALON PHARMACEUTICALS INC · on record since Oct 18, 2005

Insider trading activity of EuclidSR Partners, L.P.

Transactions on record: 15; since Apr 18, 2006

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing Feb 17, 2011

Figures computed from official regulatory filings — .

Companies where EuclidSR Partners, L.P. has traded

STANDARD BIOTOOLS INC.12 tx · Feb 17, 2011
GYRE THERAPEUTICS, INC.3 tx · Apr 18, 2006

Track record of EuclidSR Partners, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of EuclidSR Partners, L.P.

Co-insiders of EuclidSR Partners, L.P.

EuclidSR Biotechnology Partners, L.P.AVALON PHARMACEUTICALS INC +2
EuclidSR Associates, L.P.GYRE THERAPEUTICS, INC. +1
Whitaker Raymond JAVALON PHARMACEUTICALS INC +1
ADVIESBEHEER GIMV LIFE SCIENCES NVAVALON PHARMACEUTICALS INC
BARNES JEFFREY TAVALON PHARMACEUTICALS INC
BARRETT M JAMESGYRE THERAPEUTICS, INC.
BARRIS PETER JGYRE THERAPEUTICS, INC.
BARTHELEMY NICOLASSTANDARD BIOTOOLS INC.
Bencherif MerouaneGYRE THERAPEUTICS, INC.
Beneden Patrick VanAVALON PHARMACEUTICALS INC
Bergmann Joshua BenjaminGYRE THERAPEUTICS, INC.
Biomedical Sciences Investment Fund Pte Ltd.STANDARD BIOTOOLS INC.
BIOTECHNOLOGY VALUE FUND II LPGYRE THERAPEUTICS, INC.
BIOTECHNOLOGY VALUE FUND L PGYRE THERAPEUTICS, INC.
BLIXT CHARLES AGYRE THERAPEUTICS, INC.
Bol David KAVALON PHARMACEUTICALS INC
Brennan Jeffrey PGYRE THERAPEUTICS, INC.
BROWN JULIA RGYRE THERAPEUTICS, INC.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-47,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	47,400	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	320,063	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	66,991	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-320,063	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	66,991	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-66,991	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	47,400	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-47,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-66,991	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	320,063	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-320,063	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Apr 18, 2006	OtherD (derivative)	-2,021,505	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Apr 18, 2006	Other	1,509,401	—	n/a (No price was disclosed in the filing)	SEC
GYRE THERAPEUTICS, INC.Listing on record	Apr 18, 2006	OtherD (derivative)	-6,016,529	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-47,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	47,400	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	320,063	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	66,991	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-320,063	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	66,991	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-66,991	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	47,400	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-47,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-66,991	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	Other	320,063	—	n/a (No price was disclosed in the filing)	SEC
STANDARD BIOTOOLS INC.Listing on record	Feb 17, 2011	OtherD (derivative)	-320,063	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Apr 18, 2006	OtherD (derivative)	-2,021,505	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Apr 18, 2006	Other	1,509,401	—	n/a (No price was disclosed in the filing)	SEC
GYRE THERAPEUTICS, INC.Listing on record	Apr 18, 2006	OtherD (derivative)	-6,016,529	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC